Aug 2026· Experimental Gerontology· pp.
113304
· 0 citations· 83 references
Medicine
TL;DR
ML models show promising discriminative performance for DKD prediction, but the evidence is severely limited by high heterogeneity, lack of external validation and reporting of calibration metrics, and poor methodological transparency.
Abstract
Background
Machine learning (ML) has emerged as a promising tool for predicting diabetic kidney disease (DKD), yet the performance and clinical utility of these models remain unclear. We conducted a systematic review and meta-analysis to evaluate ML models for DKD prediction.
Methods
We systematically searched seven databases from inception to May 16, 2026. Studies developing or validating ML models for DKD diagnosis were included. Quality was assessed using the Prediction model Risk of Bias Assessment Tool (PROBAST) and its AI extension (PROBAST+AI), and reporting completeness was evaluated using the Transparent Reporting of a multivariable prediction model for Individual Prognosis or Diagnosis (TRIPOD) statement and its AI extension (TRIPOD+AI). Pooled sensitivity, specificity, and area under the curve (AUC) were estimated using bivariate random-effects models.
Results
Sixty-six models were included. The pooled AUC was 0.926 (95% CI: 0.898-0.947), with sensitivity of 0.83 (95% CI: 0.79-0.86) and specificity of 0.90 (95% CI: 0.87-0.93). Neural networks achieved the highest AUC (0.973), followed by random forest (0.910). However, heterogeneity was substantial (I2 > 85%). Meta-regression identified model type (P = 0.019) and study design (P = 0.037) as significant effect modifiers.
Conclusions
ML models show promising discriminative performance for DKD prediction, but the evidence is severely limited by high heterogeneity, lack of external validation and reporting of calibration metrics, and poor methodological transparency. Future research must prioritize external validation, calibration assessment, standardized reporting, and prospective impact studies.
Objectives This study aimed to systematically evaluate the predictive performance of machine learning (ML)–based models for predicting hypoglycemia in Chinese patients with diabetes. Methods We systematically searched PubMed, Embase, Web of Science, the Cochrane Library, CINAHL, CNKI, and Wanfang databases from incepti...
Jin-Hua Yan, Yan-Ping Song, Y. Du et al.· PLoS ONE· 0 citations
Abstract Background Machine learning (ML) models are increasingly used to predict acute kidney injury (AKI), but validation quality and clinical readiness remain uncertain. Objective This systematic review and meta-analysis aimed to summarize discrimination performance and implementation-relevant gaps for AKI occurrenc...
Hui-Yu Xiao, Jing-Jing Liang, Gao-Ming Li et al.· Journal of Medical Internet...· 0 citations
Evidence on ML-based risk prediction models for T2DM applicable to primary care remains limited despite growing interest in AI for diabetes prediction; greater emphasis is needed on external validation, calibration, prospective implementation, and evaluation across diverse primary care populations before widespread cli...
Rashita Ravi, J. Olickal· Frontiers in Public Health· 0 citations
AI/ML models show promise for predicting CV adverse events in patients with cancer; however, clinical applicability is constrained by insufficient preprocessing transparency, limited external validation, and inadequate calibration reporting.
Li-Wei Wu, Minh-Anh Le-Dang, B. Okoye et al.· Expert review of pharmacoeco...· 0 citations
This systematic review synthesized studies that used Nigerian clinical data to develop supervised ML models for CKD prediction or diagnosis and found major limitations included small and heterogeneous datasets, limited interpretability, inadequate external validation and limited translation of models into routine clini...
Hauwa Ahmad Amshi, Saratu Yusuf Ilu, Usman Muhammad Kadai· FUDMA Journal of Sciences· 0 citations
Artificial neural networks, ensemble models, and support vector machines may improve warfarin dose prediction compared with conventional methods, but the current evidence should be interpreted cautiously.
R. Noviyani, H. Nguyen, Khang L. T. Duong et al.· Journal of Applied Pharmaceu...· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.